LLY vs PFE — stock comparison
Eli Lilly and Company (LLY) vs Pfizer Inc. (PFE): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, LLY grades higher (A 84 vs B 61). Not investment advice.
1-year price performance — higher line = stronger return
■ LLY +37.7%■ PFE +10.6%Past year, both rebased to 100
| LLY | PFE | |
|---|---|---|
| Traddx grade | A (84) | B (61) |
| Price | $1,156.15 | $27.32 |
| Today | 1.14% | -0.35% |
| P/E | 40.30 | 17.50 |
| Net margin | 33.90% | 14.60% |
| Revenue (TTM) | $75,931.80M | $60,792.00M |
| Debt / equity | — | 1.36 |
| 52-week high | $1,292.65 | $29.21 |
| 52-week low | $783.85 | $23.62 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open LLY live → Open PFE live →